logo image
search icon
Global Needle-Free Injectors Market

Needle-Free Injectors Market Size, Share & Trends Analysis Report By Applications (Drug Delivery, Oncology, Pain Management, Vaccine delivery, Cosmetic, Other Applications) By Type, By Technology, By Product, By End-Users, By Delivery Site, By Usage, Region And Segment Forecasts, 2023-2031.

Report ID : 1189 | Published : 2023-07-14 | Pages: 180 | Format: PDF/EXCEL

The Needle-Free Injectors Market Size is valued at 140.4 Million in 2022 and is predicted to reach 614.8 Million by the year 2031 at a 17.90 % CAGR during the forecast period for 2023-2031.

Needle-Free Injectors Market

Needle-free injectors are an innovative way to introduce various medicines into patients without piercing the skin with a traditional needle. Needle-free injection systems are safer, effective, and more suitable as compared to conventional needles. These systems are available in different forms, such as power sprays, edible products, inhalers, and skin patches. Usage of these injectors can reduce the number of needle stick accidents and associated problems.

The growing demand for self-injection devices, advanced medical infrastructure, growing geriatric population, rising prevalence of chronic and infectious diseases, lack of reusability of traditional needles, increasing healthcare expenditures, and the rising need for vaccination are the major driving factors of the needle-free injectors market. Pharmaceutical companies focus on developing advanced, safe, and pain-free injectors to fulfill the growing demand for self-injection devices. Therefore, launching new quality products in the market is expected to fuel the growth of the needle-free injectors market during the forecast period. However, the high manufacturing cost of needle-free injections and the lack of trained personnel are likely to limit the market growth during the forecast period.

The needle-free injectors market is classified based on applications, load, technology, end-users, delivery site, usage, and region. The applications segment comprises drug delivery, vaccines, cosmetics, and other applications. The drug delivery segment is expected to dominate this market in the near future due to the rising chronic diseases and geriatric population. By load, the market is segmented into liquid injections, powder injections, projectile injections. The liquid segment is anticipated to hold a significant market share in the coming days due to its rapid administration and flexible nature. By technology, the market is classified into spring-loaded jet injectors, battery-powered jet injectors, gas-powered jet injectors. The market comprises hospitals, veterinary hospitals, specialty clinics, home care settings, and other end-users based on end-users. 

The market is grouped into intradermal injectors, intramuscular injectors, and subcutaneous injectors in terms of delivery site. The subcutaneous injectors segment is expected to grow rapidly over the forecast years due to its speed and low cost.  Based on the usage, the market is segmented into reusable needle-free injectors and disposable needle-free injectors. Geographically, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East, and Africa. North America is expected to hold the highest share of this market during the forecast period, followed by Europe due to the high prevalence of chronic diseases and the advancement of medical technologies.

Competitive Landscape

Some of The Key Players in The Needle-Free Injectors Market:

  • ASTS Enterprises (Aunt) Pty Ltd
  • Weston Medical
  • PharmaJet
  • Crossject
  • PenJet® Corporation
  • Caretek Medical
  • Pfizer
  • Antares Pharma, Inc.
  • InjexUK
  • Gaungzhou Medsinglong Medical Equipment Company Ltd.
  • Zogenix
  • D'Antonio Consultants International, Inc.
  • AcuShot Needle Free
  • InsuJet
  • QS Medical Technology Co., Ltd
  • MIKA MEDICAL CO.
  • Other Prominent Players

The Needle-Free Injectors Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 140.4 Million

Revenue Forecast In 2031

USD 614.8 Million

Growth Rate CAGR

CAGR of 17.90 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Applications, By Type, By Product, By Technology, By End-Users, By Delivery Site, By Usage

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Pfizer (US), Antares Pharma, Inc. (US), Injex UK (UK), Gaungzhou Medsinglong Medical Equipment Company Ltd. (China), Zogenix (US), D'Antonio Consultants International, Inc. (US), AcuShot Needle Free (Canada), InsuJet (The Netherlands), QS Medical Technology Co., Ltd (China), MIKA MEDICAL CO. (South Korea), and Others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Needle-Free Injectors Market Snapshot

Chapter 4. Global Needle-Free Injectors Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Key Trends in the Market

4.8. COVID 19 Impact Analysis

Chapter 5. Needle-Free Injectors Market Segmentation 1: By Types Estimates & Trend Analysis

5.1. By Applications & Market Share, 2020 & 2030

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Applications:

5.2.1. Drug Delivery

5.2.2. Vaccines

5.2.3. Cosmetic

5.2.4. Other Applications

Chapter 6. Needle-Free Injectors Market Segmentation 2: By Load Estimates & Trend Analysis

6.1. By Load & Market Share, 2020 & 2030

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Load:

6.2.1. Liquid Injections

6.2.2. Powder Injections

6.2.3. Projectile Injections

Chapter 7. Needle-Free Injectors Market Segmentation 3: By Technology Estimates & Trend Analysis

7.1. By Technology Analysis & Market Share, 2020 & 2030

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Technology:

7.2.1. Spring-loaded jet injector

7.2.2. Battery-powered jet injector

7.2.3. Gas-powered jet injector

Chapter 8. Needle-Free Injectors Market Segmentation 4: By End-Users Estimates & Trend Analysis

8.1. By End-Users Analysis & Market Share, 2020 & 2030

8.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:

8.2.1. Hospitals

8.2.2. Veterinary Hospitals

8.2.3. Speciality Clinics

8.2.4. Home Care Settings

8.2.5. Other End-Users

Chapter 9. Needle-Free Injectors Market Segmentation 4: By Delivery Site Estimates & Trend Analysis

9.1. By Delivery Site Analysis & Market Share, 2020 & 2030

9.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Delivery Site:

9.2.1. Intra dermal injectors

9.2.2. Intramuscular injectors

9.2.3. Subcutaneous injectors

Chapter 10. Needle-Free Injectors Market Segmentation 4: By Usage Estimates & Trend Analysis

10.1. By Usage Analysis & Market Share, 2020 & 2030

10.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Usage:

10.2.1. Reusable Needle Free Injectors

10.2.2. Disposable Needle Free Injectors

Chapter 11. Needle-Free Injectors Market Segmentation 5: Regional Estimates & Trend Analysis

11.1. North America

11.1.1. North America Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Applications, 2019-2030

11.1.2. North America Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Load, 2019-2030

11.1.3. North America Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Technology, 2019-2030

11.1.4. North America Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2019-2030

11.1.4.1. U.S.

11.1.4.2. Canada

11.2. Europe

11.2.1. Europe Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) By Applications, 2019-2030

11.2.2. Europe Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Load, 2019-2030

11.2.3. Europe Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) By Technology, 2019-2030

11.2.4. Europe Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) by country, 2019-2030

11.2.4.1. Germany

11.2.4.2. Poland

11.2.4.3. France

11.2.4.4. Italy

11.2.4.5. Spain

11.2.4.6. UK

11.2.4.7. Rest of Europe

11.3. Asia Pacific

11.3.1. Asia Pacific Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) By Applications, 2019-2030

11.3.2. Asia Pacific Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Load, 2019-2030

11.3.3. Asia Pacific Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) By Technology, 2019-2030

11.3.4. Asia Pacific Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) by country, 2019-2030

11.3.4.1. China

11.3.4.2. India

11.3.4.3. Japan

11.3.4.4. Australia

11.3.4.5. Rest of Asia Pacific

11.4. Latin America

11.4.1. Latin America Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) By Applications, (US$ Million) 2019-2030

11.4.2. Latin America Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Load, 2019-2030

11.4.3. Latin America Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) By Technology, (US$ Million) 2019-2030

11.4.4. Latin America Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2019-2030

11.4.4.1. Brazil

11.4.4.2. Rest of Latin America

11.5. MEA

11.5.1. MEA revenue Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) By Applications, (US$ Million) 2019-2030

11.5.2. MEA Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Load, 2019-2030

11.5.3. MEA revenue Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) By Technology, (US$ Million) 2019-2030

11.5.4. MEA revenue Needle-Free Injectors Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2019-2030

11.5.4.1. South Africa

11.5.4.2. Rest of MEA

Chapter 12. Competitive Landscape

12.1. Major Mergers and Acquisitions/Strategic Alliances

12.2. Company Profiles

12.2.1. ASTS Enterprises (Aunt) Pty Ltd

12.2.2. Weston Medical

12.2.3. PharmaJet

12.2.4. Crossject

12.2.5. PenJet® Corporation

12.2.6. Caretek Medical

12.2.7. Pfizer

12.2.8. Antares Pharma, Inc.

12.2.9. InjexUK

12.2.10. Gaungzhou Medsinglong Medical Equipment Company Ltd.

12.2.11. Zogenix

12.2.12. D'Antonio Consultants International, Inc.

12.2.13. AcuShot Needle Free

12.2.14. InsuJet

12.2.15. QS Medical Technology Co., Ltd

12.2.16. MIKA MEDICAL CO.

12.2.17. 8.3. List of Other Prominent Players

Global Needle-Free Injectors Market, by Applications, Value (US$ Mn) and Volume (No. of Units)

  • Drug Delivery
  • Oncology
  • Pain Management
  • Vaccine delivery
  • Cosmetic
  • Other Applications

Needle-Free Injectors Market

Global Needle-Free Injectors Market, by type,  Value (US$ Mn) and Volume (No. of Units)

  • Liquid Injections
  • Powder Injections
  • Projectile Injections

Global Needle-Free Injectors Market, by Technology, Value (US$ Mn) and Volume (No. of Units)

  • Spring-loaded jet injector
  • Battery-powered jet injector
  • Gas-powered jet injector

Global Needle-Free Injectors Market, by End-Users, Value (US$ Mn) and Volume (No. of Units)

  • Hospitals
  • Veterinary Hospitals
  • Speciality Clinics
  • Home Care Settings
  • Other End-Users

Global Needle-Free Injectors Market, by Delivery Site, Value (US$ Mn) and Volume (No. of Units)

  • Intra dermal injectors
  • Intramuscular injectors
  • Subcutaneous injectors

Global Needle-Free Injectors Market, by Usage, Value (US$ Mn) and Volume (No. of Units)

  • Reusable Needle Free Injectors
  • Disposable Needle Free Injectors

Global Needle-Free Injectors Market, by Region, Value (US$ Mn) and Volume (No. of Units)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Needle-Free Injectors Market, by Country, Value (US$ Mn) and Volume (No. of Units)

  • U.S.
  • Canada

Europe Needle-Free Injectors Market, by Country, Value (US$ Mn) and Volume (No. of Units)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Needle-Free Injectors Market, by Country, Value (US$ Mn) and Volume (No. of Units)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Needle-Free Injectors Market, by Country, Value (US$ Mn) and Volume (No. of Units)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Needle-Free Injectors Market, by Country, Value (US$ Mn) and Volume (No. of Units)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development

Latest Strategic Developments

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

Who are the Key Players in the Global Needle-Free Injectors Market?

The Needle-Free Injectors Market Size is valued at 140.4 Million in 2022 and is predicted to reach 614.8 Million by the year 2031.

The Needle-Free Injectors Market is expected to grow at a 17.90 % CAGR during the forecast period for 2023-2031.

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4500
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach